Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ezekowitz

Showing results (721-730 of 842) with videos related to

Pageof 85
Sort By:
Circulation. Heart Failure|July 3, 2025
Guideline-Directed Medical Therapy Use in the STRONG-HF TrialXiang Zhang, Beth Davison, Marianna Adamo, et al.
Journal of the American College of Cardiology|May 31, 2024
Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF ProgramMark C Petrie, Barry A Borlaug, Javed Butler, et al.
Circulation. Heart Failure|July 7, 2023
Background Medical Therapy and Clinical Outcomes From the VICTORIA TrialJustin A Ezekowitz, Ciaran J McMullan, Cynthia M Westerhout, et al.
Journal of Cardiac Failure|August 30, 2025
Assessing Benefit in Heart Failure Patients with Reduced Ejection Fraction: Analysis of the VICTORIA Trial Using Novel Prognostic Risk StratificationChristopher M O'Connor, Sarah Rathwell, Devan V Mehrotra, et al.
European Journal of Heart Failure|October 25, 2019
Is plasma renin activity associated with worse outcomes in acute heart failure? A secondary analysis from the BLAST-AHF trialRayan Jo Rachwan, Javed Butler, Sean P Collins, et al.
The New England Journal of Medicine|September 1, 2009
Dabigatran versus warfarin in patients with atrial fibrillationStuart J Connolly, Michael D Ezekowitz, Salim Yusuf, et al.
International Journal of Cardiology|February 12, 2013
Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudySean van Diepen, L Kristin Newby, Renato D Lopes, et al.
Clinical Cardiology|August 19, 2023
Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD-AF and ORBIT-AF registriesToon Wei Lim, Alan John Camm, Saverio Virdone, et al.
JAMA|October 20, 2020
Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical TrialPaul W Armstrong, Carolyn S P Lam, Kevin J Anstrom, et al.
JAMA Cardiology|April 23, 2020
Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical TrialMona Fiuzat, Justin Ezekowitz, Wendimagegn Alemayehu, et al.
Pageof 85

Showing results (721-730 of 842) with videos related to

Sort By:
Pageof 85
Circulation. Heart Failure|July 3, 2025
Guideline-Directed Medical Therapy Use in the STRONG-HF TrialXiang Zhang, Beth Davison, Marianna Adamo, et al.
Journal of the American College of Cardiology|May 31, 2024
Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF ProgramMark C Petrie, Barry A Borlaug, Javed Butler, et al.
Circulation. Heart Failure|July 7, 2023
Background Medical Therapy and Clinical Outcomes From the VICTORIA TrialJustin A Ezekowitz, Ciaran J McMullan, Cynthia M Westerhout, et al.
Journal of Cardiac Failure|August 30, 2025
Assessing Benefit in Heart Failure Patients with Reduced Ejection Fraction: Analysis of the VICTORIA Trial Using Novel Prognostic Risk StratificationChristopher M O'Connor, Sarah Rathwell, Devan V Mehrotra, et al.
European Journal of Heart Failure|October 25, 2019
Is plasma renin activity associated with worse outcomes in acute heart failure? A secondary analysis from the BLAST-AHF trialRayan Jo Rachwan, Javed Butler, Sean P Collins, et al.
The New England Journal of Medicine|September 1, 2009
Dabigatran versus warfarin in patients with atrial fibrillationStuart J Connolly, Michael D Ezekowitz, Salim Yusuf, et al.
International Journal of Cardiology|February 12, 2013
Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudySean van Diepen, L Kristin Newby, Renato D Lopes, et al.
Clinical Cardiology|August 19, 2023
Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD-AF and ORBIT-AF registriesToon Wei Lim, Alan John Camm, Saverio Virdone, et al.
JAMA|October 20, 2020
Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical TrialPaul W Armstrong, Carolyn S P Lam, Kevin J Anstrom, et al.
JAMA Cardiology|April 23, 2020
Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical TrialMona Fiuzat, Justin Ezekowitz, Wendimagegn Alemayehu, et al.
Pageof 85